Search results for "DIET"

showing 10 items of 4602 documents

Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis

2021

BackgroundSmoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established.MethodsWe included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary …

2474medicine.medical_specialtyRC620-627Health (social science)Coronavirus disease 2019 (COVID-19)infectious diseaseMedicine (miscellaneous)Health outcomesSepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointRisk of mortality1506030212 general & internal medicineNutritional diseases. Deficiency diseasesOriginal Researchpulmonary diseaseNutrition and Dieteticsbusiness.industry2524Clinical courseCOVID-19medicine.diseaseFormer Smoker030228 respiratory systemSmoking statusbusinessBMJ Nutrition, Prevention & Health
researchProduct

3,5-DIIODO-L-THYRONINE-INDUCED MODIFICATION IN PITUITARY-THYROID AXIS IN RATS FED HIGH-FAT DIET. A PRELIMINARY REPORT

2014

Experimental observations highlight that the administration of 3,5-diiodo-L-thyronine (T2) may decrease the body weight and the plasma levels of cholesterol and triglycerides and may prevent the onset of hepatic steatosis in rats fed diets rich in lipids (HFD). On the basis of these findings we have carried out some in vivo studies to evaluate the effects of increased levels of T2 on pituitary thyroid axis function in HFD rats. Fifteeen Wistar male rats were divided in 3 groups. The first group (N) was fed with a standard diet. The second group (G) was fed with a diet high in fat (HDF), while the third group (GT2) was additionally administered intraperitoneally with T2 (70 ug/100g body weig…

35-DIIODO-L-THYRONINE HIGH-FAT DIETSettore BIO/09 - Fisiologia
researchProduct

ROLE OF 3,5-DIIODO-L-THYRONINE ON THE PITUITARY-THYROID AXIS

2018

35-DIIODO-L-THYRONINESettore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct

Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system

2015

Small interfering RNAs (siRNAs) have the potential to be of therapeutic value for many human diseases. So far, however, a serious obstacle to their therapeutic use is represented by the absence of appropriate delivery systems able to protect them from degradation and to allow an efficient cellular uptake. In this work we developed a siRNA delivery system based on inulin (Inu), an abundant and natural polysaccharide. Inu was functionalized via the conjugation with diethylenetriamine (DETA) residues to form the complex Inu-DETA. We studied the size, surface charge and the shape of the Inu-DETA/siRNA complexes; additionally, the cytotoxicity, the silencing efficacy and the cell uptake-mechanis…

3003Small interfering RNAJHH6CellPharmaceutical ScienceEndocytosisCell LineIn vivoCell Line TumormedicinePolyaminesGene silencingHumansMicropinocytosisRNA Small InterferingCytotoxicityChemistry16HBEInulinEndocytosisDiethylenetriamine (DETA)Cell biologyInu-DETA copolymermedicine.anatomical_structureBiochemistryCytoplasmSettore CHIM/09 - Farmaceutico Tecnologico ApplicativosiRNA16HBE; Diethylenetriamine (DETA); Inu-DETA copolymer; Inulin; JHH6; siRNA; 3003E2F1 Transcription Factor
researchProduct

CCDC 984188: Experimental Crystal Structure Determination

2015

Related Article: Bertrand Brizet, Victor Goncalves, Claire Bernhard, Pierre D. Harvey, Franck Denat and Christine Goze|2014|Chem.-Eur.J.|20|12933|doi:10.1002/chem.201402379

4-(28-Diethyl-55-difluoro-1379-tetramethyl-5H-6lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinin-10-yl)-N-(prop-2-yn-1-yl)benzamideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1830057: Experimental Crystal Structure Determination

2019

Related Article: Jian Yang, Yoann Rousselin, Léo Bucher, Nicolas Desbois, Frédéric Bolze, Hai-Jun Xu, Claude P. Gros|2018|ChemPlusChem|83|838|doi:10.1002/cplu.201800361

4-(28-diethyl-55-difluoro-1379-tetramethyl-5H-4lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinin-10-yl)-NN-diphenylanilineSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 868802: Experimental Crystal Structure Determination

2012

Related Article: A.Cornia, F.Felluga, V.Frenna, F.Ghelfi, A.F.Parsons, M.Pattarozzi, F.Roncaglia, D.Spinelli|2012|Tetrahedron|68|5863|doi:10.1016/j.tet.2012.04.117

66'-Diethyl-77'-diphenyl-22'33'-tetrahydro-5H5'H-7a7a'-bipyrrolo[21-b][13]thiazole-55'-dioneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1402129: Experimental Crystal Structure Determination

2016

Related Article: Carla Queirós, Andreia Leite, Maria G. M. Couto, mLuís Cunha-Silva, Giampaolo Barone, Baltazar de Castro, Maria Rangel, André M. N. Silva, Ana M. G. Silva|2015|Chem.-Eur.J.|21|15692|doi:10.1002/chem.201502093

6-(Diethylamino)-9-(4-((23-dihydroxybenzyl)carbamoyl)phenyl)-NN-diethyl-3H-xanthen-3-iminium chloride chloroform solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Does dietary salt induce autoimmunity?

2013

Two recent publications suggest that dietary salt may polarize TH17 cells and therefore increase the risk of developing autoimmune disease. Where low salt diets can readily be tested for their therapeutic effects in autoimmune disease, more work is needed to connect dietary salts with the development of immunopathology.

610 Medicine & healthBiology10263 Institute of Experimental Immunologymedicine.disease_causeImmediate early proteinAutoimmunity1307 Cell Biology03 medical and health sciences0302 clinical medicineLow-salt dietsImmunopathology1312 Molecular BiologymedicineMolecular Biology030304 developmental biologyAutoimmune disease0303 health sciencesCell Biologymedicine.diseaseResearch Highlight3. Good healthImmunology570 Life sciences; biologyInterleukin 17030215 immunologyDietary saltCell research
researchProduct

Unexpected Behavior of Enaminones: Interesting New Routes to 1,6-Naphthyridines, 2-Oxopyrrolidines and Pyrano[4,3,2-de][1,6]naphthyridines

2012

Reaction of enaminones 1a–d with 2-aminoprop-1-ene-1,1,3-tricarbonitrile (2) in the presence of AcOH/NH4OAc afforded 7-amino-5-oxo-5,6-dihydro-1,6-naphthyridine-8-carbonitrile derivatives 9a–d. On the other hand, 2-aminopyrano[4,3,2-de] [1,6]naphthyridine-3-carbonitriles 20a–c,e were the only obtained products from the reactions of 1a–d with 2 in the presence of AcOH/NaOAc, while 1d afforded [3,5-bis-(4-chloro-benzoyl)-phenyl]-(4-chloro-phenyl)-methanone 21 under the same condition. The reaction of 2 with diethyl acetylenedicarboxylate in the presence of AcOH/NH4OAc afforded (4-cyano-5-dicyanomethylene-2-oxo-2,5-dihydro-1H-pyrrol-3-yl)-acetic acid eth…

7-amino-5-oxo-56-dihydro-16-naphthyridine-8-carbonitrileMagnetic Resonance Spectroscopy2-aminoprop-1-ene-113-tricarbonitrileMolecular StructureChemistryOrganic ChemistryPharmaceutical ScienceEthyl esterMedicinal chemistryArticleAnalytical Chemistrylcsh:QD241-441Diethyl acetylenedicarboxylate3-amino-2-cyanopent-2-enedinitrilelcsh:Organic chemistryChemistry (miscellaneous)enaminonesNitrilesDrug DiscoveryTransition TemperatureMolecular Medicineenaminones; 3-amino-2-cyanopent-2-enedinitrile; 7-amino-5-oxo-56-dihydro-16-naphthyridine-8-carbonitrile; 2-aminoprop-1-ene-113-tricarbonitrileNaphthyridinesPhysical and Theoretical ChemistryMolecules
researchProduct